# ATRACURIUM BESYLATE
> **ANDA206096** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-06-22
## Drug
- **FDA Application Number:** ANDA206096
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATRACURIUM BESYLATE
- **Generic name:** Atracurium Besylate
- **Active ingredients:** ATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2017-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206096)
---
*AI Analytics · CC0 1.0*